Home / Health / Critical Stents Vanish, Japan's Children at Risk
Critical Stents Vanish, Japan's Children at Risk
8 May
Summary
- 60+ children in Japan need unavailable heart stents.
- Sales of vital pediatric heart stents were discontinued.
- Open-chest surgery is the only alternative for some.
In Japan, vital stents used to treat congenital heart disease in children have been unavailable for over three years, leaving an estimated 60 young patients awaiting essential treatment. The discontinuation of these devices in July 2023, attributed to poor profitability, means some children requiring vascular widening may face open-chest surgery instead.
This lack of access to standard international treatments is critical, as the available alternatives like balloon angioplasty offer temporary relief and multiple surgeries place a significant burden on young bodies. Experts describe the situation as dire, with pediatric treatment falling victim to market forces.
Medical device manufacturers cite limited demand for rare pediatric conditions as a reason for market withdrawal, impacting not only stents but also other critical devices like coils and balloons. This challenging landscape underscores the vulnerability of specialized medical care when profitability dictates availability.
